메뉴 건너뛰기




Volumn 30, Issue 4 SUPPL.73, 2012, Pages

Do we need guidelines to stop as well as to start biological therapies for rheumatoid arthritis?

Author keywords

Biological therapies; Discontinuation; Rheumatoid arthritis

Indexed keywords

ABATACEPT; ADALIMUMAB; BIOLOGICAL PRODUCT; CORTICOSTEROID; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; INFLIXIMAB; METHOTREXATE; PREDNISONE; TOCILIZUMAB; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

EID: 84870257368     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (12)

References (17)
  • 1
    • 77953696525 scopus 로고    scopus 로고
    • EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs
    • SMOLEN JS, LANDEWE R, BREEDVELD FC et al.: EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheum Dis 2010;69:964-75.
    • (2010) Ann Rheum Dis , vol.69 , pp. 964-975
    • Smolen, J.S.1    Landewe, R.2    Breedveld, F.C.3
  • 2
    • 77954984854 scopus 로고    scopus 로고
    • Efficacy of initial methotrexate monotherapy versus combination therapy with a biological agent in early rheumatoid arthritis: A meta-analysis of clinical and radiographic remission
    • KURIYA B, ARKEMA EV, BYKERK VP, KEYSTONE EC: Efficacy of initial methotrexate monotherapy versus combination therapy with a biological agent in early rheumatoid arthritis: a meta-analysis of clinical and radiographic remission. Ann Rheum Dis 2010;69:1298-304.
    • (2010) Ann Rheum Dis , vol.69 , pp. 1298-1304
    • Kuriya, B.1    Arkema, E.V.2    Bykerk, V.P.3    Keystone, E.C.4
  • 3
    • 80052057359 scopus 로고    scopus 로고
    • Biologies in rheumatoid arthritis-recommendations for Swiss practice
    • DUDLER J, MOLLER B, MICHEL BA, VILLAGER PM: Biologies in rheumatoid arthritis-recommendations for Swiss practice. Swiss Med Wkly 2011;141:w13189.
    • (2011) Swiss Med Wkly , vol.141
    • Dudler, J.1    Moller, B.2    Michel, B.A.3    Villager, P.M.4
  • 4
    • 1242342194 scopus 로고    scopus 로고
    • Long-term treatment of rheumatoid arthritis with tumour necrosis factor alpha blockade: Outcome of ceasing and restarting biologicals
    • BUCH MH, MARZO-ORTEGA H, BINGHAM SJ, EMERY P: Long-term treatment of rheumatoid arthritis with tumour necrosis factor alpha blockade: outcome of ceasing and restarting biologicals. Rheumatology (Oxford) 2004;43:243-4.
    • (2004) Rheumatology (Oxford) , vol.43 , pp. 243-244
    • Buch, M.H.1    Marzo-Ortega, H.2    Bingham, S.J.3    Emery, P.4
  • 5
    • 83255161975 scopus 로고    scopus 로고
    • The efficacy and safety of reinstitution of tocilizumab in patients with relapsed active rheumatoid arthritis after long-term withdrawal of tocilizumab: Retreatment of patients with rheumatoid arthritis with novel anti-IL-6 receptor antibody after a long-term interval following SAMURAI: The RONIN study
    • SAGAWA A: The efficacy and safety of reinstitution of tocilizumab in patients with relapsed active rheumatoid arthritis after long-term withdrawal of tocilizumab: retreatment of patients with rheumatoid arthritis with novel anti-IL-6 receptor antibody after a long-term interval following SAMURAI: the RONIN study. Mod Rheumatol 2011;21:352-8.
    • (2011) Mod Rheumatol , vol.21 , pp. 352-358
    • Sagawa, A.1
  • 6
    • 67649755653 scopus 로고    scopus 로고
    • Effect of discontinuing TNF-alpha antagonist therapy in patients with remission of rheumatoid arthritis
    • BROCQ O, MILLASSEAU E, ALBERT C et al.: Effect of discontinuing TNF-alpha antagonist therapy in patients with remission of rheumatoid arthritis. Joint Bone Spine 2009;76:350-5.
    • (2009) Joint Bone Spine , vol.76 , pp. 350-355
    • Brocq, O.1    Millasseau, E.2    Albert, C.3
  • 7
    • 19944431840 scopus 로고    scopus 로고
    • Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: Results from a twelve-month randomized, double-blind, placebo-controlled trial
    • QUINN MA, CONAGHAN PG, O'CONNOR PJ et al.: Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: results from a twelve-month randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2005;52:27-35.
    • (2005) Arthritis Rheum , vol.52 , pp. 27-35
    • Quinn, M.A.1    Conaghan, P.G.2    O'Connor, P.J.3
  • 8
    • 77956042108 scopus 로고    scopus 로고
    • Patients with RA in remission on TNF blockers: When and in whom can TNF blocker therapy be stopped?
    • SALEEM B, KEEN H, GOEB V et al.: Patients with RA in remission on TNF blockers: when and in whom can TNF blocker therapy be stopped? Ann Rheum Dis 2010;69:1636-42.
    • (2010) Ann Rheum Dis , vol.69 , pp. 1636-1642
    • Saleem, B.1    Keen, H.2    Goeb, V.3
  • 9
    • 77954973766 scopus 로고    scopus 로고
    • Discontinuation of infliximab after attaining low disease activity in patients with rheumatoid arthritis: RRR (remission induction by Remicade in RA) study
    • TANAKA Y, TAKEUCHI T, MIMORI T et al.: Discontinuation of infliximab after attaining low disease activity in patients with rheumatoid arthritis: RRR (remission induction by Remicade in RA) study. Ann Rheum Dis 2010;69:1286-91.
    • (2010) Ann Rheum Dis , vol.69 , pp. 1286-1291
    • Tanaka, Y.1    Takeuchi, T.2    Mimori, T.3
  • 10
    • 79959795633 scopus 로고    scopus 로고
    • Discontinuation of infliximab and potential predictors of persistent low disease activity in patients with early rheumatoid arthritis and disease activity scoresteered therapy: Subanalysis of the BeSt study
    • VAN DEN BROEK M, KLARENBEEK NB, DIRVEN L et al.: Discontinuation of infliximab and potential predictors of persistent low disease activity in patients with early rheumatoid arthritis and disease activity scoresteered therapy: subanalysis of the BeSt study. Ann Rheum Dis 2011;70:1389-94.
    • (2011) Ann Rheum Dis , vol.70 , pp. 1389-1394
    • Van Den Broek, M.1    Klarenbeek, N.B.2    Dirven, L.3
  • 11
    • 34547444116 scopus 로고    scopus 로고
    • Infliximab and methotrexate as induction therapy in patients with early rheumatoid arthritis
    • VAN DER BIJL AE, GOEKOOP-RUITERMAN YP, DE VRIES-BOUWSTRA JK et al.: Infliximab and methotrexate as induction therapy in patients with early rheumatoid arthritis. Arthritis Rheum 2007;56:2129-34.
    • (2007) Arthritis Rheum , vol.56 , pp. 2129-2134
    • Van Der Bijl, A.E.1    Goekoop-Ruiterman, Y.P.2    De Vries-Bouwstra, J.K.3
  • 12
    • 84863963952 scopus 로고    scopus 로고
    • Withdrawal of adalimumab in early rheumatoid arthritis patients who attained stable low disease activity with adalimumab plus methotrexate: Results of a phase 4, double-blind, placebo-controlled trial
    • KAVANAUGH A, EMERY P, FLEISCHMANN R et al.: Withdrawal of adalimumab in early rheumatoid arthritis patients who attained stable low disease activity with adalimumab plus methotrexate: results of a phase 4, double-blind, placebo-controlled trial. Arthritis Rheum 2011;63:S665-S666.
    • (2011) Arthritis Rheum , vol.63
    • Kavanaugh, A.1    Emery, P.2    Fleischmann, R.3
  • 13
    • 84871407614 scopus 로고    scopus 로고
    • Discontinuation of adalimuman without functional and structural progress after attaining remission in patients with rheumatoid arthritis
    • TANAKA Y, HIRATA S, FUKUYO S et al.: Discontinuation of adalimuman without functional and structural progress after attaining remission in patients with rheumatoid arthritis. Arthritis Rheum 2011;63:S962.
    • (2011) Arthritis Rheum , vol.63
    • Tanaka, Y.1    Hirata, S.2    Fukuyo, S.3
  • 14
    • 84863417317 scopus 로고    scopus 로고
    • Efficacy of an induction therapy with adalimumab plus methotrexate versus methotrexate monotherapy in recent onset rheumatoid arthritis-an investigator initiated randomized controlled trial
    • DETER J, BASTIAN H, LISTING J et al.: Efficacy of an induction therapy with adalimumab plus methotrexate versus methotrexate monotherapy in recent onset rheumatoid arthritis-an investigator initiated randomized controlled trial. Arthritis Rheum 2011;63:S664-S665.
    • (2011) Arthritis Rheum , vol.63
    • Deter, J.1    Bastian, H.2    Listing, J.3
  • 15
    • 82955189834 scopus 로고    scopus 로고
    • Evaluation of abatacept administered subcutaneously in adults with active rheumatoid arthritis: Impact of withdrawal and reintroduction on immunogenicity, efficacy and safety (phase Iiib ALLOW study)
    • KAINE J, GLADSTEIN G, STRUSBERG I et al.: Evaluation of abatacept administered subcutaneously in adults with active rheumatoid arthritis: impact of withdrawal and reintroduction on immunogenicity, efficacy and safety (phase Iiib ALLOW study). Ann Rheum Dis 2012;71:38-44.
    • (2012) Ann Rheum Dis , vol.71 , pp. 38-44
    • Kaine, J.1    Gladstein, G.2    Strusberg, I.3
  • 16
    • 33750324355 scopus 로고    scopus 로고
    • Disconnect between inflammation and joint destruction after treatment with etanercept plus methotrexate: Results from the trial of etanercept and methotrexate with radiographic and patient outcomes
    • LANDEWÉ R, VAN DER HEIJDE D, KLARESKOG L, VAN VOLLENHOVEN R, FATENEJAD S: Disconnect between inflammation and joint destruction after treatment with etanercept plus methotrexate: results from the trial of etanercept and methotrexate with radiographic and patient outcomes. Arthritis Rheum 2006;54:3119-25.
    • (2006) Arthritis Rheum , vol.54 , pp. 3119-3125
    • Landewé, R.1    Van Der Heijde, D.2    Klareskog, L.3    Van Vollenhoven, R.4    Fatenejad, S.5
  • 17
    • 84867398615 scopus 로고    scopus 로고
    • Down-titration and discontinuation of infliximab in rheumatoid arthritis patients with stable low disease activity and stable treatment: An observational cohort study
    • Apr. 13. Epub ahead of print
    • VAN DER MAAS A, KIEVIT W, VAN DEN BEMT BJ, VAN DEN HOOGEN FH, VAN RIEL PL, DEN BROEDER AA: Down-titration and discontinuation of infliximab in rheumatoid arthritis patients with stable low disease activity and stable treatment: an observational cohort study. Ann Rheum Dis y2012 Apr. 13. [Epub ahead of print]
    • (2012) Ann Rheum Dis
    • Van Der Maas, A.1    Kievit, W.2    Van Den Bemt, B.J.3    Van Den Hoogen, F.H.4    Van Riel, P.L.5    Den Broeder, A.A.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.